|
|
Volumn 59, Issue 5, 2002, Pages 689-691
|
|
Experimental neurotherapeutics: Leaps and bounds
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINO ACID DECARBOXYLASE;
ANTICONVULSIVE AGENT;
BETA INTERFERON;
BIOLOGICAL MARKER;
CATECHOL METHYLTRANSFERASE;
CATECHOL METHYLTRANSFERASE INHIBITOR;
CHOLINERGIC RECEPTOR STIMULATING AGENT;
COPOLYMER;
DNA;
DOPAMINE RECEPTOR STIMULATING AGENT;
FIBRINOLYTIC AGENT;
MESSENGER RNA;
MONOAMINE OXIDASE INHIBITOR;
RILUZOLE;
SEROTONIN AGONIST;
UBIDECARENONE;
AMYOTROPHIC LATERAL SCLEROSIS;
BLOOD BRAIN BARRIER;
BRAIN INFARCTION;
CEREBROVASCULAR DISEASE;
CHRONIC PAIN;
CLINICAL TRIAL;
COGNITIVE DEFECT;
EDITORIAL;
ELECTROENCEPHALOGRAM;
GENE THERAPY;
HUMAN;
HUNTINGTON CHOREA;
INTRACTABLE EPILEPSY;
MIGRAINE;
NEUROLOGIC DISEASE;
NUCLEAR MAGNETIC RESONANCE IMAGING;
PARKINSON DISEASE;
PELIZAEUS MERZBACHER DISEASE;
PRIORITY JOURNAL;
|
|
EID: 0036096916
PISSN: 00039942
EISSN: None
Source Type: Journal
DOI: 10.1001/archneur.59.5.689 Document Type: Editorial |
|
Times cited : (2)
|
|
References (20)
|
